南昌大学学报(医学版)
南昌大學學報(醫學版)
남창대학학보(의학판)
ACTA ACADEMIAE MEDICINAE JIANGXI
2014年
5期
1-5
,共5页
程细高%贾惊宇%吴添龙%李健%张磊磊%殷明
程細高%賈驚宇%吳添龍%李健%張磊磊%慇明
정세고%가량우%오첨룡%리건%장뢰뢰%은명
miR-140-5P%软骨终板退变%microRNA 芯片
miR-140-5P%軟骨終闆退變%microRNA 芯片
miR-140-5P%연골종판퇴변%microRNA 심편
miR-140-5P%cartilaginous endplate degeneration%microRNA microarray
目的:探讨表达谱芯片初步分析 microRNA差异表达是否参与调控颈椎软骨终板退变。方法选择25例颈椎软骨终板退变、需要行手术治疗的患者为病例组,15例无椎间盘软骨终板退变患者为对照组。选取病例组2例和对照组2例标本进行microRNA芯片差异表达分析。然后采用miRCURYTM LNA 18.0表达谱芯片进行原位杂交,由 Axon GenePix 4000B microarray扫描仪采集芯片荧光值。芯片结果经病例组15例和对照组15例标本进行 Real-time PCR和Western blot验证。结果病例组发现22个上调和19个下调 microRNA。Real-time PCR验证:病例组miR-140-5P表达量低于对照组的3倍、miR-140-5P的靶基因 Adamts-5和 Dnpep的表达量分别高于对照组的3倍和3.5倍(均P<0.05)。miR-140-5P 与 Adamts-5和 Dnpep 的 miRNA表达呈负相关(r=-0.84、-0.76,均P<0.05)。Western blot结果示:病例组软骨终板 Adamts-5和 Dnpep的蛋白表达分别为0.66±0.46和0.57±0.32,均高于对照组软骨终板的0.22±0.06和0.26±0.08(均P<0.05)。结论本研究首次报道了 miR-140-5P参与调控颈椎软骨终板退变。进一步研究miR-140-5P不仅有利于揭示软骨终板退变的分子生物学机制,而且其日后也可能成为治疗椎间盘退变的有效靶工具。
目的:探討錶達譜芯片初步分析 microRNA差異錶達是否參與調控頸椎軟骨終闆退變。方法選擇25例頸椎軟骨終闆退變、需要行手術治療的患者為病例組,15例無椎間盤軟骨終闆退變患者為對照組。選取病例組2例和對照組2例標本進行microRNA芯片差異錶達分析。然後採用miRCURYTM LNA 18.0錶達譜芯片進行原位雜交,由 Axon GenePix 4000B microarray掃描儀採集芯片熒光值。芯片結果經病例組15例和對照組15例標本進行 Real-time PCR和Western blot驗證。結果病例組髮現22箇上調和19箇下調 microRNA。Real-time PCR驗證:病例組miR-140-5P錶達量低于對照組的3倍、miR-140-5P的靶基因 Adamts-5和 Dnpep的錶達量分彆高于對照組的3倍和3.5倍(均P<0.05)。miR-140-5P 與 Adamts-5和 Dnpep 的 miRNA錶達呈負相關(r=-0.84、-0.76,均P<0.05)。Western blot結果示:病例組軟骨終闆 Adamts-5和 Dnpep的蛋白錶達分彆為0.66±0.46和0.57±0.32,均高于對照組軟骨終闆的0.22±0.06和0.26±0.08(均P<0.05)。結論本研究首次報道瞭 miR-140-5P參與調控頸椎軟骨終闆退變。進一步研究miR-140-5P不僅有利于揭示軟骨終闆退變的分子生物學機製,而且其日後也可能成為治療椎間盤退變的有效靶工具。
목적:탐토표체보심편초보분석 microRNA차이표체시부삼여조공경추연골종판퇴변。방법선택25례경추연골종판퇴변、수요행수술치료적환자위병례조,15례무추간반연골종판퇴변환자위대조조。선취병례조2례화대조조2례표본진행microRNA심편차이표체분석。연후채용miRCURYTM LNA 18.0표체보심편진행원위잡교,유 Axon GenePix 4000B microarray소묘의채집심편형광치。심편결과경병례조15례화대조조15례표본진행 Real-time PCR화Western blot험증。결과병례조발현22개상조화19개하조 microRNA。Real-time PCR험증:병례조miR-140-5P표체량저우대조조적3배、miR-140-5P적파기인 Adamts-5화 Dnpep적표체량분별고우대조조적3배화3.5배(균P<0.05)。miR-140-5P 여 Adamts-5화 Dnpep 적 miRNA표체정부상관(r=-0.84、-0.76,균P<0.05)。Western blot결과시:병례조연골종판 Adamts-5화 Dnpep적단백표체분별위0.66±0.46화0.57±0.32,균고우대조조연골종판적0.22±0.06화0.26±0.08(균P<0.05)。결론본연구수차보도료 miR-140-5P삼여조공경추연골종판퇴변。진일보연구miR-140-5P불부유리우게시연골종판퇴변적분자생물학궤제,이차기일후야가능성위치료추간반퇴변적유효파공구。
Objective To investigate whether the differential miRNA expression is correlated with cartilaginous endplate degeneration in cervical vertebrae.Methods Twenty-five patients needing surgical treatment for cartilaginous endplate degeneration in cervical vertebrae (case group)and 1 5 normal subj ects(control group)were selected in this study.The differential miR-NA expression was analyzed using the microarray in 2 patients from case group and 2 subj ects from control group.In situ hybridization was performed using miRCURY LNA Array(version, 18.0),and fluorescence arrays were analyzed on an Axon GenePix 4000B scanner.The results of microarray analysis were further verified by real-time PCR and Western blot in 1 5 patients and 1 5 normal subjects.Results The expressions of 22 miRNAs were up-regulated and expressions of 19 miRNAs were down-regulated in patients with cartilaginous endplate degeneration in cervical ver-tebrae.Real-time PCR showed that the expression of miR-140-5P in case group was 3 times lower than that in control group.Furthermore,the expressions of miR-140-5P target gene Adamts-5 and Dnpep in case group were 3 and 3.5 times higher than those in control group,respectively(P<0.05).The expression of miR-140-5P was negatively correlated with the expressions of Adamts-5 and Dnpep(r=-0.84 and r=-0.76,respectively;P<0.05).Western blot showed that the pro-tein expressions of Adamts-5 and Dnpep in case group(0.66±0.46 and 0.57±0.32,respectively) were higher than those in control group(0.22±0.06 and 0.26±0.08,respectively)(P<0.05). Conclusion We reported,for the first time,an involvement of miR-140-5P in cartilaginous end-plate degeneration in cervical vertebrae.Further study on miR-140-5P will contribute to the clari-fication of molecular biological mechanisms of cartilaginous endplate degeneration and will be an efficient tool for targeted treatment of intervertebral disc degeneration.